Dharmarajan Sriram

15.7k total citations · 1 hit paper
440 papers, 13.5k citations indexed

About

Dharmarajan Sriram is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Dharmarajan Sriram has authored 440 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 275 papers in Organic Chemistry, 231 papers in Molecular Biology and 166 papers in Infectious Diseases. Recurrent topics in Dharmarajan Sriram's work include Synthesis and biological activity (188 papers), Tuberculosis Research and Epidemiology (130 papers) and Cancer therapeutics and mechanisms (123 papers). Dharmarajan Sriram is often cited by papers focused on Synthesis and biological activity (188 papers), Tuberculosis Research and Epidemiology (130 papers) and Cancer therapeutics and mechanisms (123 papers). Dharmarajan Sriram collaborates with scholars based in India, United States and Türkiye. Dharmarajan Sriram's co-authors include Perumal Yogeeswari, Subbu Perumal, Erik De Clercq, Vagolu Siva Krishna, Gopal Nath, S. N. Pandeya, Palaniappan Senthilkumar, Tanushree Ratan Bal, Jonnalagadda Padma Sridevi and Raju Ranjith Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Scientific Reports.

In The Last Decade

Dharmarajan Sriram

431 papers receiving 13.1k citations

Hit Papers

Synthesis, antibacterial, antifungal and anti-HIV activit... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers

Dharmarajan Sriram
Dharmarajan Sriram
Citations per year, relative to Dharmarajan Sriram Dharmarajan Sriram (= 1×) peers Perumal Yogeeswari

Countries citing papers authored by Dharmarajan Sriram

Since Specialization
Citations

This map shows the geographic impact of Dharmarajan Sriram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharmarajan Sriram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharmarajan Sriram more than expected).

Fields of papers citing papers by Dharmarajan Sriram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharmarajan Sriram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharmarajan Sriram. The network helps show where Dharmarajan Sriram may publish in the future.

Co-authorship network of co-authors of Dharmarajan Sriram

This figure shows the co-authorship network connecting the top 25 collaborators of Dharmarajan Sriram. A scholar is included among the top collaborators of Dharmarajan Sriram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharmarajan Sriram. Dharmarajan Sriram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sriram, Dharmarajan, et al.. (2025). Covalent Linker-Functionalized Nanometer-Thick Gold Film Electrodes for Noninvasive Electrochemical C-Reactive Protein Detection. ACS Applied Nano Materials. 8(46). 22455–22465.
2.
Kljun, Jakob, Sanja Škaro Bogojević, Dharmarajan Sriram, et al.. (2024). Silver(I) and gold(III) complexes with miconazole: The influence of the metal ion on the antimicrobial activity of the coordinated azole. Inorganica Chimica Acta. 574. 122393–122393. 2 indexed citations
3.
Murahari, Manikanta, et al.. (2024). N‐Substituted piperazine‐coupled imidazo[2,1‐b]thiazoles as inhibitors of Mycobacterium tuberculosis: Synthesis, evaluation, and docking studies. Drug Development Research. 85(1). e22153–e22153. 2 indexed citations
4.
Jadav, Surender Singh, et al.. (2024). Thiazolotriazoles As Anti-infectives: Design, Synthesis, Biological Evaluation and In Silico Studies. ACS Omega. 9(8). 8846–8861. 2 indexed citations
7.
Sathe, Bhaskar R., et al.. (2023). Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives. Bioorganic & Medicinal Chemistry Letters. 97. 129551–129551. 19 indexed citations
8.
Ramesh, Deepthi, Balaji Gowrivel Vijayakumar, Mitali Chatterjee, et al.. (2022). First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Archiv der Pharmazie. 355(4). e2100440–e2100440. 9 indexed citations
9.
Konduri, Srihari, Jyothi Prashanth, Vagolu Siva Krishna, et al.. (2021). Sacubitril‐Based Urea and Thiourea Derivatives as Novel Inhibitors for Anti‐Tubercular against Dormant Tuberculosis. ChemistrySelect. 6(16). 3869–3874. 20 indexed citations
10.
Arumugam, Natarajan, Abdulrahman I. Almansour, Raju Suresh Kumar, et al.. (2020). A stereo, regioselective synthesis and discovery of antimycobaterium tuberculosis activity of novel β-lactam grafted spirooxindolopyrrolidine hybrid heterocycles. Arabian Journal of Chemistry. 14(2). 102938–102938. 16 indexed citations
11.
Arumugam, Natarajan, Abdulrahman I. Almansour, Raju Suresh Kumar, et al.. (2020). Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their anti-Mycobacterium tuberculosis activity. RSC Advances. 10(40). 23522–23531. 54 indexed citations
12.
Ozadali‐Sari, Keriman, Oya Ünsal Tan, Dharmarajan Sriram, & Ayla Balkan. (2019). Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents. Turkish Journal of Pharmaceutical Sciences. 16(4). 432–436. 7 indexed citations
13.
Krishna, Vagolu Siva, Chandrasekar Balachandran, Krishnan Rangan, et al.. (2019). The design and green synthesis of novel benzotriazoloquinolinyl spirooxindolopyrrolizidines: antimycobacterial and antiproliferative studies. New Journal of Chemistry. 43(44). 17511–17520. 18 indexed citations
14.
Krishna, Vagolu Siva, et al.. (2019). Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity. European Journal of Medicinal Chemistry. 188. 112010–112010. 36 indexed citations
15.
Krishna, Vagolu Siva, et al.. (2018). Identification of Novel Metabolites and Screening of Antimicrobial and Anti-mycobacterium tuberculosis Activity of Bauhinia Purpurea Flowers. international journal of green and herbal chemistry. 7(3). 6 indexed citations
16.
Munikumar, Manne, et al.. (2018). In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases. Journal of Molecular Graphics and Modelling. 82. 20–36. 17 indexed citations
18.
Muthusubramanian, Shanmugam, et al.. (2012). Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 22(4). 1643–1648. 19 indexed citations
19.
Alagarsamy, V., et al.. (2000). Anti HIV And Antibacterial Activities Of Some Disubstitutedquinazolones And Their Bio-Isostere Disubstitutedthienopyrimidones. Indian Journal of Pharmaceutical Sciences. 62(6). 433. 10 indexed citations
20.
Sriram, Dharmarajan, et al.. (1999). Synthesis, Antibacterial, Antifungal And Anti-HIV Activity Of Schiff And Mannich Bases Of Isatin With N-[6-Chlorobenzothiazol-2-yl] Thiosemicarbazide. Indian Journal of Pharmaceutical Sciences. 61(6). 358. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026